Mebendazole is just a regular anti-parasitic drug.
But researchers started noticing something unexpected.
It might affect how certain cancer cells grow.
👇
1)
This drug has been used for years
to treat worms and parasitic infections.
Nothing new.
But what changed… is how we started looking at it.
2)
In lab studies, researchers observed:
Mebendazole can interfere
with how cells divide and multiply.
And that’s important.
3)
Because cancer cells depend heavily on rapid division.
If that process is disturbed…
their growth slows down.
4)
Some studies show it affects structures inside the cell
called microtubules.
These are essential for cell division.
5)
When these structures don’t form properly…
cells can’t divide normally.
And eventually, they stop functioning.
6)
In certain lung cancer cell studies,
this led to something called “cell death”.
Not instantly.
But over time.
7)
But here’s what matters 👇
8)
Most of this research is still in lab settings
or early-stage studies.
Not final conclusions.
9)
And that’s important to understand.
Because what works in controlled conditions
doesn’t always translate directly to real-world treatment.
10)
Still, it opens up an interesting direction:
Looking at existing drugs in a completely new way.
11)
“Sometimes progress doesn’t come from new drugs…
but from seeing old ones differently.”
12)
Understanding the difference between early research
and proven treatment is important.
Stay informed.
Follow @skymeds_store for real, research-based health content.
Share this Scrolly Tale with your friends.
A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.